Celsion (NSDQ:CLSN) and Children’s National Health System are teaming up to tackle refractory solid tumors in pediatric patients using a heat-activated chemotherapy drug and noninvasive ultrasound. The Phase I clinical trial, which launched last November, is the 1st of its kind in the U.S. Lawrenceville, N.J.-based Celsion’s ThermoDox is a heat-activated liposomal doxorubicin. In combination with MRI, […]
Celsion
New heart valves have a steep learning curve | MassDevice.com On Call
MASSDEVICE ON CALL — Major complications occur frequently in patients undergoing transcatheter aortic valve implantation procedures, according to an analysis of data from the Edwards Lifesciences (NYSE:EW) Partner TAVI trial published in Interventional Surgery.
Boston Scientific sells Prolieve device back to Medifocus for $5M
Updated June 28, 2012, at 12:45 p.m. with comments from Medifocus.
Medical device titan Boston Scientific (NYSE:BSX) sold the Prolieve business back to Medifocus (PINK:MDFZF) in a deal valued at $5 million.